Yaou Flora Sheng

View Profile »

The Association of State Policies and Opioid Analgesic Amount Dispensed from Retail Pharmacies

2025
Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic

2024
Buprenorphine Prescribing Practices for Older Adults in 2019 and 2020

2024
Use of Inpatient Psychiatric Facilities by Medicare Beneficiaries with Dementia

2024
Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment

2023
Buprenorphine Treatment Episodes During the First Year of COVID: A Retrospective Examination of Treatment Initiation and Retention

2023
Changes in Nursing Home Use Following Medicaid-Supported Expanded Access to Home- and Community-Based Services for Older Adults With Dementia

2023
Differences in Medicaid Expansion Effects on Buprenorphine Treatment Utilization by County Rurality and Income: A Pharmacy Data Claims Analysis from 2009-2018

2023
An Exploratory Analysis of Differential Prescribing of High-Risk Opioids by Insurance Type Among Patients Seen by the Same Clinician

2023
The Effect of State Policies on Rates of High-Risk Prescribing of an Initial Opioid Analgesic

2022
Trends in the Concurrent Prescription of Opioids and Gabapentin in the US, 2006 to 2018

2022
Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: A Retrospective Analysis

2021
Patient, Prescriber, and Community Factors Associated with Filled Naloxone Prescriptions Among Patients Receiving Buprenorphine 2017–18

2021
Practice Expense Data Collection and Methodology: Phase II Final Report

2021
Practice Expense Methodology and Data Collection Research and Analysis: Interim Phase II Report

2020

Federally Funded Research Divisions

Social and Economic Policy Divisions

International

Yaou Flora Sheng

The Association of State Policies and Opioid Analgesic Amount Dispensed from Retail Pharmacies

Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic

Buprenorphine Prescribing Practices for Older Adults in 2019 and 2020

Use of Inpatient Psychiatric Facilities by Medicare Beneficiaries with Dementia

Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment

Buprenorphine Treatment Episodes During the First Year of COVID: A Retrospective Examination of Treatment Initiation and Retention

Changes in Nursing Home Use Following Medicaid-Supported Expanded Access to Home- and Community-Based Services for Older Adults With Dementia

Differences in Medicaid Expansion Effects on Buprenorphine Treatment Utilization by County Rurality and Income: A Pharmacy Data Claims Analysis from 2009-2018

An Exploratory Analysis of Differential Prescribing of High-Risk Opioids by Insurance Type Among Patients Seen by the Same Clinician

The Effect of State Policies on Rates of High-Risk Prescribing of an Initial Opioid Analgesic

Trends in the Concurrent Prescription of Opioids and Gabapentin in the US, 2006 to 2018

Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: A Retrospective Analysis

Patient, Prescriber, and Community Factors Associated with Filled Naloxone Prescriptions Among Patients Receiving Buprenorphine 2017–18

Practice Expense Data Collection and Methodology: Phase II Final Report

Practice Expense Methodology and Data Collection Research and Analysis: Interim Phase II Report